(Commercial Product)
Available Dosage Strengths
2.5 mg / 0.5 mL | 5 mg / 0.5 mL | 7.5 mg / 0.5 mL | 10 mg / 0.5 mL | 12.5 mg / 0.5 mL | 15 mg / 0.5 mL
Want to Prescribe?
Tirzepatide (Zepbound®) Injection (Commercial Product by Eli Lilly Company)
Tirzepatide Description1-4
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is a once-weekly subcutaneous injection indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or who are overweight.
References
Mechanism of Action1-3
Tirzepatide exerts its effects through dual incretin receptor agonism, targeting both:
Adverse Reactions1-4
Most adverse reactions are gastrointestinal in nature and dose-dependent:
Contraindications & Precautions1-4
Contraindications:
Precautions:
Store refrigerated at 36°F to 46°F (2°C – 8°C). Discard within 28 days of puncture or according to the beyond-use date. Do not freeze. Keep out of reach of children.
This information is for educational purposes only.
Wells Pharmacy Network distributes certain FDA-approved commercial products that are manufactured by third-party pharmaceutical companies. These products are not compounded or manufactured by Wells Pharmacy Network. Product availability at the time of dispensing may vary due to supply chain conditions.
This information is a summary. It may not cover all possible drug information about this product. For complete product information, refer to the manufacturer’s prescribing information and labeling. Call your doctor for medical advice and/or about side effects. You may report side effects to the FDA at 1-800-FDA-1088. A Wells Pharmacy Network pharmacist will be happy to answer any questions. For consultation, please call 1-800-622-4510.
